Synthesis and Characterization of Deuterated Detomidine for Use in Equine Medication Regulation
Journal of Labelled Compounds and Radiopharmaceuticals · 2026-03 · 69 (3)
DOI: 10.1002/jlcr.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 16.03.2026. Verfasst von Justin C Holmes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Deuterium, Imidazoles. Die Arbeit nennt 17 Literaturangaben. Gefördert von: National Institute of Food and Agriculture, U.S. Department of Agriculture, National Institute of Food and Agriculture.
Abstract (Originalsprache)
Detomidine, 5‐[(2,3‐dimethylphenyl)methyl]‐1 H ‐imidazole, is a tranquilizer/sedative/analgesic widely used in equine medicine and regulated by several different analyte concentrations of detomidine and its hydroxydetomidine and carboxydetomidine metabolites in plasma and urine. Accurate regulatory quantitation of detomidine at low picogram/mL concentrations requires the availability of a stable isotope internal standard of detomidine; however, to the best of our knowledge, no certified deuterated internal standard of detomidine is commercially available and its synthesis has not been reported. Here, we report the first synthesis and characterization of detomidine‐ d , prepared in six sequential steps consisting of a deuterium–hydrogen exchange, diazotization, Grignard coupling, hydrogenolysis, and palladium‐catalyzed deuterium–hydrogen exchange. This overall route gave detomidine‐ d in moderate chemical yield with each intermediate purified to > 90% purity as determined by RP‐HPLC. Regiochemistry and isotopic enrichment were confirmed by 1 H NMR and LC/MS, demonstrating a viable method for the incorporation of three deuterium atoms into the detomidine scaffold. This internal standard will allow for precise LC/MS quantitation of detomidine at regulatory threshold concentrations, enabling accurate detection and quantitation of picogram/mL concentrations in equine blood and urine samples, thereby supporting regulatory compliance for equine medication control programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA.
- Center for Pharmaceutical Research and Innovation, College of Pharmacy and Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.
- Frontier BioPharm, LLC, Richmond, Kentucky, USA.
- Equine Integrated Medicine, Georgetown, Kentucky, USA.
- New York Drug Testing and Research Program, Ithaca, New York, USA.
- Consulting Toxicologist, Wellington, Florida, USA.
ORCID-Profile: Justin C Holmes, Adedamola S Arojojoye, Samuel G Awuah, Clara K Fenger, George A Maylin, Thomas Tobin
Förderung
- National Institute of Food and Agriculture, U.S. Department of Agriculture
- National Institute of Food and Agriculture
Zitieren
APA
Holmes, J. C., Arojojoye, A. S., Awuah, S. G., Eisenberg, R., Fenger, C. K., Maylin, G. A., Brewer, K., & Tobin, T. (2026). Synthesis and Characterization of Deuterated Detomidine for Use in Equine Medication Regulation. Journal of Labelled Compounds and Radiopharmaceuticals, 69(3). https://doi.org/10.1002/jlcr.70023
Vancouver
Holmes JC, Arojojoye AS, Awuah SG, Eisenberg R, Fenger CK, Maylin GA, et al. Synthesis and Characterization of Deuterated Detomidine for Use in Equine Medication Regulation. Journal of Labelled Compounds and Radiopharmaceuticals. 2026;69(3). doi:10.1002/jlcr.70023
BibTeX
@article{Holmes2026,
author = {Holmes, Justin C and Arojojoye, Adedamola S and Awuah, Samuel G and Eisenberg, Rodney and Fenger, Clara K and Maylin, George A and Brewer, Kimberly and Tobin, Thomas},
title = {Synthesis and Characterization of Deuterated Detomidine for Use in Equine Medication Regulation},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2026},
volume = {69},
number = {3},
doi = {10.1002/jlcr.70023}
}
EUVIMED